ExpreS2ion Biotech Holding AB (DE:5JD)
FRANKFURT:5JD
Germany Market
Holding DE:5JD?
Track your performance easily

ExpreS2ion Biotech Holding AB (5JD) Cash flow

2 Followers

ExpreS2ion Biotech Holding AB Cash Flow

DE:5JD's free cash flow for Q3 2022 was kr-23.43M. For the 2022 fiscal year, DE:5JD's free cash flow was decreased by kr-27.30M and operating cash flow was kr-23.34M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
kr -64.49Mkr -45.65Mkr -18.18Mkr -12.69Mkr -12.88Mkr -8.61M
Investing Cash Flow
kr 3.55Mkr -100.92Mkr -1.08Mkr -2.50Mkr -813.00Kkr -206.00K
Financing Cash Flow
kr 61.51Mkr 74.55Mkr 123.38Mkr 12.57Mkr 18.59Mkr 3.98M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 393.95Mkr 37.11Mkr 106.83Mkr 5.42Mkr 6.25Mkr 1.51M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
kr 75.96Mkr 83.30Mkr 143.18Mkr 8.00Mkr 19.26Mkr 4.01M
Issuance Of Debt
--kr 3.17Mkr 4.75Mkr 0.00-
Repayment Of Debt
kr -1.24Mkr -1.36M---kr 0.00
Free Cash Flow
kr -64.68Mkr -46.36Mkr -19.06Mkr -13.37Mkr -13.69Mkr -8.81M
Domestic Sales
------
Foreign Sales
------
Currency in SEK

ExpreS2ion Biotech Holding AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis